0000000000000000000000000000000000000000000000000000000000000000214346
Research payments
$10,055,118
Through program year 2025, $10,055,118 in research payments was reported against 0000000000000000000000000000000000000000000000000000000000000000214346, across 30 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $4,186,830 | 15 |
| 2024 | Research | $2,102,072 | 6 |
| 2021 | Research | $2,244,620 | 5 |
| 2019 | Research | $1,521,595 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.